(S (NP (NP (VBG Existing) (NNS studies)) (PP (IN for) (NP (JJ automated) (NN melanoma) (NN diagnosis)))) (VP (VBP are) (VP (VBN based) (PP (IN on) (NP (NP (JJ single-time) (NN point) (NNS images)) (PP (IN of) (NP (NNS lesions))))))) (. .))
(S (ADVP (RB However)) (, ,) (S (NP (JJ melanocytic) (NNS lesions)) (ADVP (IN de) (NN facto)) (VP (VBP are) (VP (ADVP (RB progressively)) (VBG evolving)))) (CC and) (, ,) (S (ADVP (RB moreover)) (, ,) (NP (JJ benign) (NNS lesions)) (VP (MD can) (VP (VB progress) (PP (IN into) (NP (JJ malignant) (NN melanoma)))))) (. .))
(S (S (VP (VBG Ignoring) (NP (NP (JJ cross-time) (JJ morphological) (NNS changes)) (PP (IN of) (NP (NNS lesions)))))) (ADVP (RB thus)) (VP (MD may) (VP (VB lead) (PP (TO to) (NP (NP (VB misdiagnosis)) (PP (IN in) (NP (NN borderline) (NNS cases))))))) (. .))
(S (PP (VBN Based) (PP (IN on) (NP (DT the) (NN fact) (SBAR (IN that) (S (NP (VBZ dermatologists)) (VP (RB diagnose) (NP (JJ ambiguous) (NN skin) (NNS lesions)) (PP (IN by) (S (VP (VBG evaluating) (NP (DT the) (NN dermoscopic) (NNS changes)) (PP (IN over) (NP (NN time))) (PP (IN via) (NP (JJ follow-up) (NN examination)))))))))))) (, ,) (PP (IN in) (NP (DT this) (NN study))) (, ,) (NP (PRP we)) (VP (VBP propose) (NP (NP (DT an) (JJ automated) (NN framework)) (PP (IN for) (NP (NN melanoma) (NN diagnosis))) (VP (VBG using) (NP (JJ sequential) (NN dermoscopic) (NNS images))))) (. .))
(S (S (VP (TO To) (VP (VB capture) (NP (NP (DT the) (JJ spatio-temporal) (NN characterization)) (PP (IN of) (NP (NN dermoscopic) (NN evolution))))))) (, ,) (NP (PRP we)) (VP (VBP construct) (NP (PRP$ our) (NN model)) (PP (IN in) (NP (NP (DT a) (JJ two-stream) (NN network) (NN architecture)) (SBAR (WHNP (WDT which)) (ADJP (JJ capable) (PP (IN of) (S (VP (ADVP (RB simultaneously)) (VBG learning) (NP (NP (NN appearance) (NNS representations)) (PP (IN of) (NP (JJ individual) (NNS lesions)))) (SBAR (IN while) (S (VP (VBG performing) (NP (JJ temporal) (NN reasoning)) (PP (IN on) (NP (DT both) (NP (JJ raw) (NNS pixels) (NN difference)) (CC and) (NP (JJ abstract) (NNS features) (NN difference))))))))))))))) (. .))
(S (NP (PRP We)) (VP (VBP collect) (NP (NP (CD 184) (NNS cases)) (PP (IN of) (NP (JJ serial) (NN dermoscopic) (NN image) (NNS data))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ consists) (PP (IN of) (NP (NP (ADJP (RB histologically) (VBN confirmed)) (CD 92) (JJ benign) (NNS lesions)) (CC and) (NP (CD 92) (NN melanoma) (NNS lesions))))))) (, ,)) (S (VP (TO to) (VP (VB evaluate) (NP (NP (DT the) (NN effectiveness)) (PP (IN of) (NP (DT the) (VBN proposed) (NN method)))))))) (. .))
(S (NP (PRP$ Our) (NN model)) (VP (VBD achieved) (NP (NP (NNP AUC)) (PP (IN of) (NP (NP (CD 74.34) (NN %)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (ADJP (ADJP (ADJP (NP (CD ~8) (NN %)) (JJR higher)) (PP (IN than) (NP (NP (DT that)) (PP (IN of) (S (VP (ADVP (RB only)) (VBG using) (NP (JJ single) (NNS images)))))))) (CC and) (ADJP (ADJP (NP (CD ~6) (NN %)) (JJR higher)) (PP (IN than) (NP (NP (DT the) (ADJP (RB widely) (VBN used)) (NN sequence) (VBG learning) (NNS model)) (VP (VBN based) (PP (IN on) (NP (NNP LSTM))))))))))))))) (. .))
